Biological

Heplisav-B clinical trials

studies test it: 12
open now: 1
in phase 3: 4
first study started: 2006

Keep track of what changes. Save the Heplisav-B studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

HEPLISAV-B: 6
HEPLISAV: 6
Hepatitis B vaccine (recombinant), adjuvanted: 3

Studies by the year they started

12 studies that test it; most in 2007 (2)

Studies that test Heplisav-B, by start year
Year	Studies
2006	1
2007	2
2009	1
2010	1
2013	1
2014	1
2018	1
2019	2
2020	1
2025	1

By phase

A phase 1/2 study counts in both.

Phase 1: 5
Phase 2: 3
Phase 3: 4

What it is tested for

Each study’s main condition, where its own words name it.

Hepatitis B: 8
HIV Infections: 1
Kidney Diseases: 1
Hepatitis B, Chronic: 1

Who runs them

Industry 8 · Other 4

Dynavax Technologies Corporation (8) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Baylor Research Institute (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · University of Maryland, Baltimore (1)

Studies

Open first, then newest update. How each study uses Heplisav-B is read from its arms, and is right about nine times in ten.